' Game Changer': Treat Diabetes and Also Reduce CV Risk'Game Changer': Treat Diabetes and Also Reduce CV Risk

Drs Shubrook and Chamberlain discuss cardiovascular risk reduction associated with SGLT-2 inhibitors and GLP-1 agonists in T2D, and advise clinicians to'be aware. 'Medscape Family Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news

Related Links:

A study from Harvard University has found that those who gained weight after quitting smoking had a 22 percent higher risk of developing type 2 diabetes in comparison with current smokers.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
(MedPage Today) -- But diabetic individuals did have a higher risk for heart failure
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news
(Reuters Health) - People with diabetes are more likely to develop certain cancers than those without the condition, and a new analysis suggests that the increased risk is greater for women than for men.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Conclusions: Higher hs-CRP as a marker of low-grade inflammation was detected in prepubertal children exposed to maternal GDM, but no differences were seen in height, weight, BMI, or markers of glucose and lipid metabolism compared to control children. This finding may reflect an ongoing process of metabolic changes in children born after a GDM pregnancy.Horm Res Paediatr
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research
(Reuters Health) - Weight gain can be a big concern for smokers who want to quit, and a new study suggests that it raises the odds of developing type 2 diabetes in the first six years after quitting.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Publication date: Available online 15 August 2018Source: SteroidsAuthor(s): Julius Fink, Masahito Matsumoto, Yoshifumi TamuraAbstractSedentary lifestyle and over-nutrition are the main causes of obesity and type 2 diabetes (T2D). However, the same causes are major triggers of hypogonadism. Many T2D patients show low testosterone levels while hypogonadal men seem to be prone to become diabetic. Testosterone plays a major role in the regulation of muscle mass, adipose tissue, inflammation and insulin sensitivity and is therefore indirectly regulating several metabolic pathways, while T2D is commonly triggered by insulin resi...
Source: Steroids - Category: Drugs & Pharmacology Source Type: research
A growing number of studies suggest that getting a handle on a few key risk factors can bring type 2 diabetes under control. Lowering blood sugar, for instance, reduces the risk of additional health problems, such as heart disease and stroke related to the disease. But most of these studies have focused on studying one risk factor — like blood sugar, cholesterol or blood pressure — at a time. In a new study published in the New England Journal of Medicine, researchers analyzed what happens to death rates and other health problems when people control up to five known risk factors for type 2 diabetes. The study ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthytime medicine Source Type: news
(MedPage Today) -- Diabetes risk eventually returns to normal, and outweighed by overall survival boost
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
Shares in ReShape Lifesciences (NSDQ:RSLS) have fell 30% today after the weight loss device maker posted second quarter earnings that missed expectations on Wall Street and announced it terminated plans for an upcoming offering. The San Clemente, Calif.-based company posted losses of $35.3 million, or $14.23 per share, on sales of $653,369 for the three months ended June 30, seeing losses grow 415.3% while sales grew 602.1% compared with the same period last year. Losses per share were significantly behind the $1.79 consensus on Wall Street. “We have made a lot of meaningful progress this quarter at ReShape, wit...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat reshapelifesciences Source Type: news
In conclusion, the current coculture system of HAMSCs/HBMSCs can be a potential therapeutic material for advancing bone and vascular regeneration against DM-induced glucolipotoxicity. PMID: 30103897 [PubMed - in process]
Source: Biochimie - Category: Biochemistry Authors: Tags: Biochimie Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Health | Heart | Primary Care